Back
NVIDIA Corp. Vs. Spyre Therapeutics, Inc. Industry Stock Comparison
Buy
51
NVDA
NVIDIA Corp.
Last Price:
$183.44
Seasonality Move:
12%
Buy
59
SYRE
Spyre Therapeutics, Inc.
Last Price:
$33.54
Seasonality Move:
1.04%
Buy
51
NVIDIA Corp. (NVDA)
is a Buy
Is NVIDIA Corp. a Buy, Sell or Hold?
-
The current NVIDIA Corp. [NVDA] share price is $179.59. The Score for NVDA is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
-
NVDA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
59
Spyre Therapeutics, Inc. (SYRE)
is a Buy
Is Spyre Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Spyre Therapeutics, Inc. [SYRE] share price is $32.20. The Score for SYRE is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
SYRE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NVDA Stock Price Chart
What is NVIDIA Corp.'s stock price today?
-
The NVIDIA Corp. share price today is $179.59Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVDA is experiencing selling pressure, which indicates risk of future bearish movement.
SYRE Stock Price Chart
What is Spyre Therapeutics, Inc.'s stock price today?
-
The Spyre Therapeutics, Inc. share price today is $32.20Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SYRE is experiencing buying pressure, which is a positive indicator for future bullish movement.
NVDA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.78 | Sell |
| Relative Strength Index (14 RSI): | 44.48 | Sell |
| Chaikin Money Flow: | -117681670 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (179.71 - 198.29) | Sell |
| Bollinger Bands (100): | (173.21 - 189.87) | Sell |
SYRE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.2 | Buy |
| Relative Strength Index (14 RSI): | 75.59 | Buy |
| Chaikin Money Flow: | 1275786 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.31 - 27.91) | Buy |
| Bollinger Bands (100): | (15.21 - 23.57) | Buy |
NVDA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 179.69 | Sell |
| 20-day SMA: | 185.35 | Sell |
| 50-day SMA: | 186.88 | Sell |
| 200-day SMA: | 154.31 | Buy |
| 8-day EMA: | 180.69 | Sell |
| 20-day EMA: | 183.97 | Sell |
| 50-day EMA: | 184.34 | Sell |
| 200-day EMA: | 162.48 | Buy |
SYRE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.68 | Buy |
| 20-day SMA: | 25.43 | Buy |
| 50-day SMA: | 22.39 | Buy |
| 200-day SMA: | 17.74 | Buy |
| 8-day EMA: | 28.74 | Buy |
| 20-day EMA: | 26.36 | Buy |
| 50-day EMA: | 23.25 | Buy |
| 200-day EMA: | 20.2 | Buy |
NVIDIA Corp. Earnings Growth & NVDA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.25 per share, an increase next quarter of $0.19 per share, an increase this year of $1.72 per share, and an increase next year of $1.73 per share.
Spyre Therapeutics, Inc. Earnings Growth & SYRE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.18 per share, and a decrease next year of $0.60 per share.
NVIDIA Corp. Technical Analysis
| Nov 19 | Nov 20 | Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 19 | 20 | 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Spyre Therapeutics, Inc. Technical Analysis
| Nov 19 | Nov 20 | Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 19 | 20 | 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||